[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Regeneron Regeneron

Regeneron posts on X about sanofi, breakingnews, eu the most. They currently have XXXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

• X Week XXXXX +14%
• X Month XXXXX -XX%
• X Months XXXXXX +54%
• X Year XXXXXX +502%

Mentions: X #

• X Week X -XX%
• X Month XX -XX%
• X Months XX +288%
• X Year XX +179%

Followers: XXXXXX #

• X Week XXXXXX +0.03%
• X Month XXXXXX +0.05%
• X Months XXXXXX +1.10%
• X Year XXXXXX +0.69%

CreatorRank: undefined #

Social Influence

Social category influence stocks XX%

Social topic influence sanofi 25%, breakingnews 12.5%, eu XXXX%

Top accounts mentioned or mentioned by @mikej_ha_ha @grok @pitchdecks @sanofi @scifest4stem @stock6996 @tesseratx @3primeanalytica @peerview @bicep_crypto @checkorphan @ebsummiteurope @paulbiogeek @deryatr_ @pietjepsvpuk @twagner85 @stream_rx @thelancet @americanheart @galienfdn

Top assets mentioned Sanofi (SNY)

Top Social Posts

Top posts by engagements in the last XX hours

"At #ACAAI25 were presenting results from our Phase X trial in allergic fungal rhinosinusitis (AFRS) in people aged X and older. These pivotal data also support the sBLA that was recently accepted for Priority Review by the FDA. Learn more: CC: @sanofi"
X Link 2025-11-07T13:53Z 33.5K followers, 1255 engagements

"Phase X data on our novel investigational factor XI antibodies were published in @TheLancet and presented at the @American_Heart Scientific Sessions. Read more: #AHA25"
X Link 2025-11-08T15:58Z 33.5K followers, 1194 engagements

"At #ASH25 we're presenting new and updated data from our hematology portfolio and pipeline. Learn more about how this will highlight the next wave of potential novel approaches across a range of blood cancers and disorders"
X Link 2025-11-13T12:07Z 33.5K followers, XXX engagements

"#BreakingNews: The European Commission (EC) has approved our medicine as an adjuvant treatment for adults with cutaneous squamous cell carcinoma (#CSCC) with high risk of disease recurrence after surgery and radiation"
X Link 2025-11-19T12:08Z 33.5K followers, 1091 engagements

"We are pleased to announce that the U.S. FDA has approved our medicine for the treatment of macular edema following retinal vein occlusion (RVO) and a monthly dosing option in all approved indications"
X Link 2025-11-19T22:06Z 33.5K followers, 1938 engagements

"Were pleased to share that the European Commission has approved our medicine for the treatment of #ChronicSpontaneousUrticaria (CSU) in certain adults and adolescents aged 12+ in the EU. CC: @Sanofi"
X Link 2025-11-25T12:00Z 33.5K followers, XXX engagements

"#BreakingNews: Were excited to collaborate with @TesseraTx to combine our strengths in genetics and genetic medicines with Tesseras Gene Writing genome engineering technology"
X Link 2025-12-01T12:10Z 33.5K followers, 2164 engagements

"Today at #ASH25 we presented new data investigating our bispecific therapy in newly diagnosed #multiplemyeloma. Learn more about the latest results. Read more:"
X Link 2025-12-07T21:35Z 33.5K followers, 1413 engagements